All manuscripts
Videos

ISCT 2024: Redefining Sustainability in CGT, Ensuring Patient Affordability and Accessibility

Share
ISCT 2024: Redefining Sustainability in CGT, Ensuring Patient Affordability and Accessibility

What this paper found

Leading industry experts discuss critical strategies to make life-changing treatments more accessible and affordable for patients during ISCT 2024. Hear from top executives at Germfree, Cellular Origins, and CellReady as they discuss innovative solutions to overcome industry challenges. Moderated by ScaleReady.

Building a similar workflow?

Talk to a ScaleReady specialist about how the G-Rex® platform can support your program — from process development to clinical-scale manufacturing.

Start a conversation →